Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The "SMART" side of hypertriglyceridemia.

Atherosclerosis·2025
Same author

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.

Clinical rheumatology·2025
Same author

Clínica e Investigación en Arteriosclerosis, the Iberoamerican journal of lipidology and vascular risk.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis·2022
Same author

Serum sex hormone-binding globulin levels are reduced and inversely associated with intrahepatic lipid content and saturated fatty acid fraction in adult patients with glycogen storage disease type 1a.

Journal of endocrinological investigation·2022
Same author

High protein prescription in methylmalonic and propionic acidemia patients and its negative association with long-term outcome.

Clinical nutrition (Edinburgh, Scotland)·2021
Same author

Preferences of people with Type 2 diabetes for diabetes care: a discrete choice experiment.

Diabetic medicine : a journal of the British Diabetic Association·2019

相关实验视频

Updated: Jul 12, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.1K

家庭组合性高脂血症:神话还是现实?

M C G J Brouwers1,2, B Klop3, J Ribalta4,5,6

  • 1Department of Internal Medicine, Division of Endocrinology and Metabolic Disease, Maastricht UMC+, Maastricht, the Netherlands.

Current atherosclerosis reports
|April 1, 2025
PubMed
概括

家庭组合性高脂血症 (FCHL) 是一种多基因疾病,不仅仅由特定的基因变异来定义. 目前的理解将重点从单个基因转移到影响脂质水平的多个遗传因素.

关键词:
脂肪肝疾病是一种脂肪肝疾病.自由脂肪酸是自由的脂肪酸.超脂血症是因为高脂血症三甲酸甘油三甲酸甘油是什么在VLDL的过度生产.

更多相关视频

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.9K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.0K

相关实验视频

Last Updated: Jul 12, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.1K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.9K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.0K

科学领域:

  • 遗传学 遗传学 是一个
  • 代谢障碍 代谢障碍 代谢障碍
  • 心血管疾病 心血管疾病

背景情况:

  • 家庭组合性高脂血症 (FCHL) 最初于1973年被描述为一种与早发性心肌梗塞相关的自体主导性疾病.
  • FCHL的定义和遗传基础一直是持续研究和辩论的主题.

研究的目的:

  • 提供FCHL特征的代谢和遗传异常的历史概述.
  • 将历史发现与最近的遗传和人口研究相结合,提出FCHL的新病理生理学概念.
  • 为管理患有FCHL表型的患者提供实际指导.

主要方法:

  • 关于FCHL的历史文献的审查.
  • 对定量性质联系研究的分析.
  • 包括来自全基因组关联研究 (GWAS) 和下一代测序 (NGS) 的数据.
  • 整合了最近基于人口和遗传学的研究结果.

主要成果:

  • 证实FCHL是一种多基因疾病,具有多个相关的基因变异,主要影响三甘水平.
  • 鉴定出的基因变异不是FCHL独有的.
  • 多种类型的高脂血症表型并不仅限于FCHL.
  • 一个新的FCHL病理生理模型已经根据综合发现开发出来.

结论:

  • FCHL是一种复杂的多基因疾病,挑战了最初的自体主导模型.
  • 了解FCHL需要将历史代谢数据与现代遗传洞察力整合起来.
  • 拟议的模型提供了一个框架,用于临床管理具有FCHL表型的个体.